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Cell populations can use aneuploidy to survive
telomerase insufﬁciency
Caroline Millet1, Darya Ausiannikava1,w, Thierry Le Bihan2, Sander Granneman2 & Svetlana Makovets1
Telomerase maintains ends of eukaryotic chromosomes, telomeres. Telomerase loss results in
replicative senescence and a switch to recombination-dependent telomere maintenance.
Telomerase insufﬁciency in humans leads to telomere syndromes associated with premature
ageing and cancer predisposition. Here we use yeast to show that the survival of telomerase
insufﬁciency differs from the survival of telomerase loss and occurs through aneuploidy. In
yeast grown at elevated temperatures, telomerase activity becomes limiting: haploid
cell populations senesce and generate aneuploid survivors—near diploids monosomic for
chromosome VIII. This aneuploidy results in increased levels of the telomerase components
TLC1, Est1 and Est3, and is accompanied by decreased abundance of ribosomal proteins. We
propose that aneuploidy suppresses telomerase insufﬁciency through redistribution of
cellular resources away from ribosome synthesis towards production of telomerase
components and other non-ribosomal proteins. The aneuploidy-induced re-balance of the
proteome via modulation of ribosome biogenesis may be a general adaptive response to
overcome functional insufﬁciencies.
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T
elomeres are ends of linear eukaryotic chromosomes,
which in most organisms are maintained by the enzyme
telomerase. Telomerase extends telomeres, thereby
compensating for telomere shortening caused by DNA replica-
tion1. In humans, the expression of the telomerase catalytic
subunit hTERT is strongly downregulated in somatic cells2.
This repression may act as a barrier to oncogenesis as
precancerous cells must overcome the problem of telomere
maintenance to proliferate indeﬁnitely. Only 10–15% of
cancers are telomerase negative and use recombination to
maintain their telomeres, while the majority reactivate enough
telomerase to keep telomeres short, but stable3. Recent discoveries
linked telomerase reactivation in some tumours to mutations
in the hTERT promoter4. However, such mutation were
not found in other telomerase-positive cancer cells5 and the
mechanisms of telomerase reactivation for these cancers remain
unknown.
In dividing yeast, telomerase loss results in gradual telomere
shortening, activation of the DNA damage checkpoint and
massive cell death followed by appearance of infrequent
survivors, which maintain telomeres via recombination6–13.
Laboratory strains of yeast Saccharomyces cerevisiae are
typically propagated at 30 C and possess 300–350 bp of
telomeric repeats (TG1-3)n (ref. 14), but at higher temperatures
the telomere length equilibrium is shorter15. When haploid,
S. cerevisiae possess 16 chromosomes and 32 telomeres
maintained by telomerase. Telomerase is a reverse trans-
criptase16 that uses an integral RNA component, TLC1 in
yeast, as a template to extend the 30 end of a telomere13. Est2 is
the yeast telomerase catalytic protein subunit while Est1 interacts
with TLC1 (ref. 17) and the telomere-binding protein Cdc13 (ref.
18) to recruit telomerase to telomeres. Est3 interacts directly with
Est1 and Est2 and stimulates Est2 catalytic activity19. All the
telomerase components are present in vivo in low abundance,
with TLC1 being the limiting factor20. Although TLC1 is
haploinsufﬁcient in diploids, the slightly shorter telomeres in
TLC1/tlc1D cells at 30 C are stable and do not limit cell
proliferation20.
Loss of any of the telomerase components does not cause
immediate cell death. DNA replication in telomerase-negative
cells leads to gradual telomere shortening until one or more
critically short telomeres, which are recognized as double-strand
breaks, trigger the DNA damage checkpoint and result in cell
cycle arrest and loss of viability6–13. This viability crisis is
followed by the generation of rare survivors that maintain their
telomeres via recombination involving either sub-telomeric
Y0 repeats (type I survivors) or telomeric (TG1-3)n repeats (type
II survivors)6,7,21.
In contrast to complete telomerase loss, telomerase insufﬁ-
ciency, when cell proliferation is limited by low amount of
telomerase, is more closely relevant to human telomere
syndromes22 and cancer. Below we show that, unlike the use of
recombination to overcome telomerase deletion, when faced with
telomerase insufﬁciency yeast cells may use chromosome-speciﬁc
aneuploidy to upregulate telomerase and maintain short but
stable telomeres. This aneuploidy leads to downregulation of
ribosomal proteins accompanied by increased abundance of
various non-ribosomal proteins and RNA, which include the
telomerase protein components Est1, Est3 and telomerase RNA
TLC1. Our results provide strong evidence that in yeast, survival
of telomerase insufﬁciency differs from overcoming telomerase
loss and can occur through aneuploidy-dependent upregulation
of telomerase. Since cancer cells are highly aneuploid23 and many
increase telomerase activity to propagate indeﬁnitely2, aneuploidy
may be an evolutionarily conserved means to elevate telomerase
activity and maintain proliferative capacity.
Results
Telomerase insufﬁciency in yeast grown at 38.5 C. Consistent
with the previously published data15, telomeres in the budding
yeast S. cerevisiae equilibrated at a shorter average length when
cells were propagated for 80 generations (four passages, each
passage equals B20 cell doublings) at higher temperatures
(Fig. 1a,b). This re-equilibration was also characteristic of the
ﬁssion yeast Schizosaccharomyces pombe when propagated at
higher temperatures, but it was not characteristic of the algae
Chlorella vulgaris (Fig. 1c,d).
Propagation of S. cerevisiae at 38.5 C for longer than 80
generations resulted in a viability crisis at passages 3–7 (Fig. 2a,
upper panel) followed by the generation of ‘temperature
survivors’ (Fig. 2a, upper, passages 8–11). The cell growth was
accompanied by activation of a DNA damage checkpoint as
evident from the phosphorylation of Rad53, the key kinase in the
pathway (Fig. 2b, upper panel). The maximum level of Rad53
phosphorylation correlated with the peak of cell viability crisis
(Fig. 2b, upper panel, passages 5–7). Analysis of telomere length
revealed that telomeres continued to shorten during earlier
passages, after which the telomeres remained short and
stable (Fig. 2c, left panel and Supplementary Fig. 1).
To test whether the cell viability crisis was elicited by critically
short telomeres, we pre-elongated telomeres by temporarily
expressing the CDC13–EST2 gene fusion24 and then selecting for
its loss before cells were propagated at 38.5 C (Fig. 2c, right
panel and Supplementary Fig. 1). We reasoned that cells with
pre-elongated telomeres would exhibit a delay in the viability
crisis as it would take longer for their telomeres to become
critically short. Telomere pre-elongation delayed both the
viability crisis and Rad53 phosphorylation until streak 11
(Fig. 2a, lower panel and Fig. 2b, lower panel). Thus, telomere
maintenance is the growth-limiting factor at 38.5 C. Analysis of
a larger number of ‘temperature survivors’ showed that the
majority possessed short and stable telomeres (Supplementary
Fig. 2a), which is a phenotype distinct from type I and II
telomerase-negative survivors (see Supplementary Fig. 2b for a
comparison). In a control experiment, deletion of either TLC1 or
EST2 at 38.5 C led to the formation of type I and type II
survivors (Supplementary Fig. 2b), indicating that survival of
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Figure 1 | Telomere length equilibrium is temperature dependent in
budding yeast S. cerevisiae and ﬁssion yeast S. pombe but not in algae
C. vulgaris. (a–d) Southern blot analysis of telomere length equilibrium
after cells were grown for four passages (B80 generations) at the
temperatures shown at the bottom of the corresponding lanes on blots.
DNA size marker is shown on the right of each blot. (a) S. cerevisiae A364a
Y0 telomeres. (b) Y0 telomeres of the three S. cerevisiae strain backgrounds,
A364a, W303 and S288c, commonly used in research. (c) S. pombe
telomeres. (d) C. vulgaris telomeres.
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telomerase loss was not inﬂuenced by the elevated temperature
and that recombination-dependent telomere maintenance can
operate at 38.5 C.
The shorter telomeres at higher growth temperature could
result from a lower rate of telomere extension, a higher rate of
telomere erosion (due to recombination or a nuclease-dependent
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Figure 2 | Viability crisis during yeast cell growth at 38.5 C is caused by telomerase insufﬁciency. (a) Plate images of serial passaging at 38.5 C of
cells after their telomeres were equilibrated at 30 C either at the wild-type length (‘normal’, upper panel) or much longer (‘pre-elongated’, lower panel).
Here and in further ﬁgures, the passage number is indicated above images. (b) DNA damage signalling activation during the passaging in a, as monitored
by Rad53 phosphorylation (Rad53-HA-P). (c) Telomere length dynamics during the passaging in a, as assayed by Southern blotting. A control sample
(C) from wild-type (WT) strain grown at 30 C is in the left most lane. (d) The effect of elevated growth temperature on the steady-state levels of
telomerase subunits Est1, Est2 and Est3, analysed by western blotting (bottom panels). All the analysed proteins contained 13myc tags at the C termini.
Equal amounts of total cell protein were loaded in each lane (see upper panels for Ponceau Red staining of total protein on blotting membranes).
(e) A second copy of EST2 but not EST1, EST3 or TLC1 suppresses telomerase insufﬁciency at 38.5 C. Serial passaging of haploid cells with an additional
copy of EST1, EST2, EST3 or TLC1 (as indicated on the left) integrated into a genomic locus of a WT strain.
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DNA degradation at telomeres) or both. To distinguish between
these possibilities, we compared the rates of telomere shortening
at 26 and 38.5 C in cells lacking telomerase (est2D or tlc1D),
exonuclease Exo1 (exo1D) or homologous recombination
(rad52D). In the wild-type control, the effect of temperature on
telomere length was readily observed after B20 generations,
became more pronounced on B40 generations and was not
affected by either exo1D or rad52D (Supplementary Fig. 3a, left
and middle panels). Furthermore, both exo1D and rad52D
mutants resembled wild-type cells by undergoing a viability crisis
at 38.5 C (Supplementary Fig. 3b) suggesting that neither Exo1-
dependent DNA degradation nor recombination at telomeres was
responsible for the viability crisis. In contrast, the growth
temperature did not affect telomere length in the telomerase
mutants, as their telomeres shortened at the same rate at 26 and
38.5 C (Supplementary Fig. 3a, right panel). Because the telomere
erosion was temperature independent, we inferred that the growth
temperature affected telomerase-dependent telomere lengthening.
The effect of growth temperature on the telomerase complex
components Est1, Est2 and Est3 was analysed and the steady-state
level of the telomerase catalytic subunit Est2 was markedly
reduced at 38.5 C (Fig. 2d). Consistent with these observations,
the cell viability crisis at 38.5 C was suppressed when a second
copy of EST2 but not EST1, EST3 or TLC1 was integrated into the
yeast genome (Fig. 2e). Therefore, the viability crisis at 38.5 C
was caused by the insufﬁciency of telomerase activity, most likely
due to limiting Est2, and we named the cells that survived the
crisis telomerase insufﬁciency survivors (TI survivors).
CHR VIII monosomy suppresses telomerase insufﬁciency.
We next analysed TI survivors generated from the propagation of
79 independent clones at 38.5 C by ﬂuorescence-activated cell
sorting (FACS). To our surprise, 32 clones possessed a DNA
content characteristic of diploid cells, but retained Mat-a pheno-
type (that is, they were not true diploids, which would express
both MATa and MATa). To test if the diploid TI survivors
(dTI survivors) maintained their telomeres via telomerase,
tlc1D/tlc1D derivatives were generated. All the telomerase-deﬁcient
dTI survivors exhibited a viability crisis (Fig. 3a) followed by the
formation of type I survivors (Fig. 3b). Therefore, the dTI survi-
vors are different from the survivors generated in response to
telomerase loss and rely on telomerase for telomere maintenance.
Analysis of DNA content throughout the propagation period at
38.5 C revealed a correlation between the timing of ploidy switch
and survivor formation (for example, Fig. 4a, streak 7), suggesting
that diploidization could be a means to adapt to telomerase
insufﬁciency. When passaged at 30 C, the dTI survivors showed
slower growth (small colonies, S strains) in comparison to either
haploid or diploid yeast, but often generated larger colonies
(L strains), that at 30 C maintained a growth rate similar to that
of wild-type yeast (Fig. 4b). The DNA content of both L and S
strains wasB2n by FACS. To uncover the difference between the
L and S strains we used array comparative genome hybridization
(aCGH) on three L/S pairs. All the three S strains had one copy
of chromosome VIII (CHRVIII) and an increased amount of
mtDNA, while the L strains regained the second copy of CHRVIII
and re-equilibrated their mtDNA to near wild-type copy number
(Fig. 4c and Supplementary Fig. 4). Thus, the dTI survivors
shared in common a ploidy transition from 1n to near 2n, with
CHRVIII monosomy and an increased mtDNA copy number.
The aCGH analysis was extended to 10 additional dTI survivors
and all of them contained a single copy of CHRVIII and increased
mtDNA. In contrast, 10 haploid TI survivors analysed by aCGH
did not show any change in relative DNA content throughout the
genome and were not analysed further.
The mtDNA increase observed in the 2n 1 dTI survivors was
not required for adaptation to telomerase insufﬁciency as yeast
lacking mtDNA (r0 cells) passaged at 38.5 C formed diploid-like
survivors with a single copy of CHRVIII (Supplementary Fig. 5).
To test if the karyotype 2n 1 (CHRVIII) suppressed telomerase
insufﬁciency in dTI survivors, a matD::KAN /MATa diploid strain
and its derivative carrying only a single copy of CHRVIII were
genetically engineered at 30 C and propagated at 38.5 C
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Figure 3 | dTI survivors require telomerase for their viability. (a) Plate images of serial passaging at 30 C of three dTI survivors after telomerase
inactivation with deletion of both copies of TLC1. (b) Telomere analysis of tlc1D/tlc1D derivatives of dTI survivors from the passage 6 shown in a (not all the
clones are shown in passaging). The right most lane shows telomeres from a control sample, wild-type cells grown at 30 C. Notice that tlc1D/tlc1D
derivatives of all the dTI survivors formed type I survivors. Ampliﬁcation of internal Y0 repeats often seen in TI survivors might be pre-disposing them to the
type I pathway after telomerase loss.
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(Fig. 4d). The complete diploid strain exhibited a mild viability
crisis at early passages (Fig. 4d) while the strain monosomic for
CHRVIII exhibited no growth defect (Fig. 4d, bottom panel).
These results demonstrate that transition to the aneuploidy 2n 1
(CHRVIII monosomy) was sufﬁcient to suppress the growth crisis
induced by telomerase insufﬁciency in haploid cells (Fig. 2a).
To assay CHRVIII stability and its dependence on telomere
length at 38.5 C we passaged colonies from a matD::KAN /MATa
diploid and its CDC13/cdc13::CDC13–EST1 derivative with longer
telomeres24. In the CDC13/CDC13 cells, CHRVIII was lost during
earlier passages but the onset of aneuploidy was signiﬁcantly
delayed in the presence of the Cdc13–Est1 fusion protein
(Supplementary Fig. 6). In contrast, both copies of chromosome
III were retained by all clones (n¼ 54). Thus, CHRVIII
aneuploidy in response to telomerase insufﬁciency is chromo-
some speciﬁc and can be observed in diploid cells.
How CHRVIII monosomy may suppress telomerase insufﬁ-
ciency. To determine the mechanism by which CHRVIII
aneuploidy enables the suppression of telomerase insufﬁciency,
we searched for genes on CHRVIII, which, when reduced to a
single copy in a diploid, would alleviate telomerase insufﬁciency
and stabilize CHRVIII. Extensive analysis of CHRVIII stability in
diploids carrying different deletions on one of the copies of
CHRVIII identiﬁed four relevant genes: PRP8, UTP9, KOG1 and
SCH9 (Supplementary Fig. 7). Heterozygosity of each of the genes
did not elicit an observable impact on CHRVIII stability (Fig. 5a).
However, when the mutations were combined in a quadruple
heterozygous diploid of the genotype þ /prp8D þ /utp9D þ
/kog1D þ /sch9D, the loss of CHRVIII was signiﬁcantly delayed
(Fig. 5a) although these mutations had only a moderate effect on
telomere length at 30 C (Supplementary Fig. 8). Utp9 plays a role
in pre-rRNA processing25. Kog1 and Sch9 are components of the
TOR signalling pathway, which positively regulates the
transcription of ribosomal protein (RP) genes26, whereas Prp8
is an essential splicing factor27. In budding yeast, introns are
found mainly in RP genes. Therefore, combined
haploinsufﬁciencies in PRP8, UTP9, KOG1 and SCH9 (and
perhaps other, yet unidentiﬁed genes on CHRVIII) might lead to
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a reduction in both the expression of RP genes and ribosome
synthesis in CHRVIII aneuploids. Because RPs constitute
B80–85% of total cell protein, we hypothesized that
downregulation of RP gene expression might signiﬁcantly
increase the translation of less abundant non-RP mRNAs, such
as Est1/2/3, explaining the suppression of telomerase insufﬁciency
in CHRVIII aneuploids.
Consistent with this model, northern blotting analysis revealed
a delay in pre-rRNA processing in aneuploids as evident from the
accumulation of 35S pre-rRNA (Fig. 5b) and a reduction in the
levels of mature 5.8S and 5S RNAs (Fig. 5c). Quantitative mass
spectrometry (MS) revealed a Z 1.5-fold decrease in the
abundance of 39 RPs in aneuploids (Fig. 5d and Supplementary
Data Set 1, group 1), accompanied by upregulation of a number
of non-RPs (Supplementary Data Set 1, group 2). Furthermore,
quantitative western blot analyses showed signiﬁcantly elevated
levels of Est1 and Est3 in aneuploids, particularly at 38.5 C
(Fig. 6). Finally, the defect in rRNA production in aneuploids
(Fig. 5b,c) was accompanied by a relative increase in the
abundance of the telomerase RNA TLC1 (Fig. 6). This increase
in the abundance of the telomerase components was required for
suppression of telomerase insufﬁciency as reductions of Est1, Est3
and TLC1 functions in the aneuploids via introduction of
heterozygous deletions in the corresponding genes led to the
re-appearance of the viability crisis at 38.5 C (Fig. 7). We
conclude that the aneuploidy-dependent increases in TLC1, Est1
and Est3 partially compensate for the lower Est2 level by
promoting telomerase complex formation and/or telomerase
recruitment to telomeres, thereby suppressing telomerase
insufﬁciency.
Discussion
Telomere length equilibrium reﬂects a balance between telomere
shortening due to the end replication problem and telomerase-
dependent telomere lengthening. Telomerase insufﬁciency
described here is a situation when telomerase cannot fully
compensate for the loss of telomeric repeats during replication
and therefore telomeres gradually shorten and a viability crisis
due to critically short telomeres occurs. At the growth
temperature of 38.5 C, the levels of the telomerase catalytic
subunit Est2 are reduced. Our genetic data suggest that this
reduction is responsible for the temperature-induced viability
crisis as an additional copy of EST2 is sufﬁcient to prevent it. Est2
binds stem–loop structures of the telomerase RNA TLC1. It has
been shown that Est2 levels are decreased in tlcD cells28 and
therefore Est2 binding to TLC1 might be required to stabilize
Est2. At the higher growth temperatures, the stability of the
duplex regions of TLC1 might be compromised, thereby
decreasing the binding of Est2 to the RNA and increasing Est2
instability.
The transition of a haploid yeast population with telomerase
insufﬁciency to aneuploidy is based on a stochastic in nature
rather than a developmentally programmed mechanism. Most
cells in the senescing population are haploid and eventually die:
the very few that survive are likely pre-existent cells, which at
some point underwent chromosome mis-segregation and became
aneuploid. This aneuploidy, which would confer a growth
disadvantage at 30 C, becomes advantageous at 38.5 C by
allowing cell survival and proliferation as a result of suppression
of the temperature-induced telomerase insufﬁciency. Conse-
quently, the population of survivors seeded by the previously
rare aneuploids becomes dominated by aneuploid cells.
The transition of the yeast population from fast-growing
haploids to slower-growing near diploids in response to
telomerase insufﬁciency is reversible, as after returning to lower
temperatures the aneuploid populations can be outgrown by
frequently arising full diploids (Fig. 4b,c). Although these diploids
have a haploid-like mating type they could easily mate to similar
diploids of the opposite mating type to generate MATa/a/a/a
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Figure 5 | Downregulation of ribosome production in CHRVIII aneuploids
might be responsible for the suppression of telomerase insufﬁciency.
(a) Combined haploinsufﬁciencies in UTP9, PRP8, SCH9 and KOG1 delay
CHRVIII loss. CHRVIII stability during serial passaging at 38.5 C. Number
of clones involved in the experiment is stated in brackets next to the
corresponding genotype. (b) rRNA processing in diploid and aneuploid cells
assayed by northern blotting (top two panels). The bottom two panels
show total RNA resolved in agarose gel and stained with ethidium bromide
before the blotting transfer. (c) CHRVIII aneuploidy results in lower
steady-state levels of mature rRNA, 5.8S and 5S, when normalized to tRNA.
All the relative amounts were normalized against diploids grown at 30 C.
Averages of three biological repeats for every experiment with error bars
representing s.d.s are shown. (d) Abundance of 103 proteins was found
reduced at least 1.5-fold in aneuploid cells, as detected by MS (Po0.05,
analysis based on at least two different peptides for each protein, see
Supplementary Data Set 1, group 1). Among them, 39 ribosomal proteins
and 6 other proteins involved in ribosome biogenesis (Utp15, Rrp5, Snu13,
Enp2, and CHRVIII-coded Nmd3 and Gar1). As expected, a large fraction of
proteins in this group are encoded by genes on CHRVIII, which is reduced
to a single copy in aneuploids. No ribosomal proteins with increased
abundance in aneuploids were detected (Supplementary Data Set 1, group 2).
See Supplementary Data Set 1 and Supplementary Tables 1–3 for the full
data set and analysis of comparative MS.
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quadruploids, which would then generate MATa/a diploids
during the initial sporulation, and haploids in the following
round of sporulation29. Therefore, the switch to CHRVIII
aneuploidy due to telomerase insufﬁciency is fully reversible
and represents a great example of genome dynamics and plasticity
in response to stress to promote cell survival and proliferation.
In the recent years, aneuploidy has been reported as a stress
adaptation mechanism in yeast and mammalian cells (reviewed
by Chen et al.30). Aneuploidy is normally not optimal for cell
ﬁtness and leads to altered cell physiology and further genomic
instability31–33. However, aneuploidy can confer growth
advantages under stress conditions such as exposure to toxins,
high osmolarity or sub-optimal nutrition, and is proposed to
drive adaptation of cell populations to changing environment34.
The previously reported cases of aneuploidy in S. cerevisiae
involved haploid yeast disomic for one or a few chromosomes.
The mechanistic links between gaining an extra chromosome and
the resultant phenotypes were often tracked to a gene(s) on that
chromosome, which, due to the increase in gene dosage, was
expressed at a higher level in the aneuploids, thereby providing
growth advantages in the altered environmental conditions. In
contrast, our study on yeast adaptation to telomerase
insufﬁciency uncovered a karyotype change from a haploid set
of chromosomes to a near-diploid set, involving a monosomy for
a single chromosome, CHRVIII. Such a karyotype switch
provides the opposite gene dosage adjustment—a twofold
decrease in the copy number for the genes on the affected
chromosome.
Interestingly, the proteome changes in the CHRVIII aneu-
ploids went far beyond the factors encoded by CHRVIII. We
observed lowered abundance of a large pool of RPs most of which
were encoded by genes on chromosomes other than CHRVIII.
The decreased abundance of RPs could be a result of either
lowered protein synthesis or increased protein degradation due to
the synthesized RPs not being incorporated into newly made
ribosomes due to unbalanced production of RPs35. We believe the
downregulated synthesis is a more likely scenario since the
genetic pursuit of CHRVIII genes relevant to the suppression of
telomerase insufﬁciency identiﬁed multiple key players in
ribosome biogenesis, such as Kog1, Sch9, Ppr8 and Utp9. The
location of the four corresponding genes (and perhaps some other
relevant, yet unidentiﬁed factors) on CHRVIII makes this
chromosome unique for its role in the modulation of ribosome
biogenesis via aneuploidy: combined haploinsufﬁciencies of these
factors in CHRVIII aneuploids result in very speciﬁc changes in
cellular metabolism, where ribosome production rate might be
decreased in an energy-saving manner, via decreased synthesis
rather than increased degradation of ribosomal components.
Because RPs constitute 80–85% of total cell protein, a 1.5-fold
decrease in the abundance of RPs would lead to an approximately
threefold increase in non-RPs (the ratio of RPs/non-RPs in
euploid cells 80–85% versus 15–20% would become 53–57%
versus 43–47% in the aneuploids). Such increases were easily
detectable for some of the most abundant non-RPs in the
aneuploids in the comparative MS analyses (Supplementary Data
Set 1 and Supplementary Tables 1–3). We also detected more
than twofold increases in the levels of the telomerase subunits
Est1 and Est3, but not Est2, by using quantitative western
blotting. Ribosomal RNA constitutes B50% of total cellular
RNA. On the basis of the observed decreases in the 5S RNA/
tRNA and 5.8S RNA/tRNA ratios and the slower processing of
35S pre-rRNA in the CHRVIII aneuploids, an overall increase in
non-ribosomal RNA in the aneuploids is highly likely, perhaps
due to the haploinsufﬁciency of UTP9. Consistent with this
hypothesis, the CHRVIII aneuploidy was also accompanied by a
fourfold increase in the telomerase RNA TLC1. Although the
abundance of Est2 was unchanged in the aneuploids, the
increases in Est1, Est3 and TLC1 levels were necessary for the
aneuploids to survive at higher growth temperature (Fig. 7). The
increased abundance of the three telomerase components might
promote assembly of the fully functional telomerase complex and
its recruitment to telomeres, thereby maximizing the usage of the
existing Est2 to ensure telomere maintenance and avoiding
telomerase insufﬁciency. Because CHRVIII aneuploidy affects
abundance of a variety of other non-RPs, cellular mechanisms
and pathways other than telomere maintenance might be affected
in a similar manner. Therefore, aneuploidy-dependent modula-
tion of ribosome biogenesis may have evolved as a general
mechanism that relies on genome plasticity to re-equilibrate
cellular metabolism in response to changing environment by
providing compensatory adjustments against growth-limiting
factors to maximize cell proliferation.
0
2
4
TL
C1
/1
8S
 in
cr
ea
se
30°C 38.5°C
2n 2n – 1
0
2
4
Es
t3
/T
P 
in
cr
ea
se
0
2
4
Es
t1
/T
P 
in
cr
ea
se
0
1
Es
t2
/T
P 
in
cr
ea
se
0
1
Figure 6 | CHRVIII aneuploidy leads to increased levels of telomerase
components. CHRVIII aneuploidy is accompanied by increased levels of
TLC1 (normalized against 18S RNA), Est1 and Est3 (Est1/2/3 are normalized
against total protein, TP). All the relative amounts are normalized
against diploids grown at 30 C, except for Est2 at 38.5 C where the
amount of Est2 was normalized against diploids grown at 38.5 C.
Comparative analyses of Est2 levels at different temperatures are shown
on separate charts as the amount of Est2 at 38.5 C was so low that
immunoprecipitations of Est2-13myc from larger volume of cell lysates were
required before the protein amounts could be compared by quantitative
western blotting. Averages of three biological repeats for every experiment
with error bars representing s.d.s are shown.
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Interestingly, the abundance of the telomerase catalytic subunit
Est2 was not affected by aneuploidy. This suggests that there
might be a feedback loop mechanism regulating the amount of
Est2 in the cell, or that Est2 synthesis might be co-regulated with
ribosome biogenesis. Ribosome biogenesis is modulated in
response to growth factors through the TOR pathway. The
TOR pathway has been linked to lifespan regulation in single-
and multicellular eukaryotes36,37 as well as to telomere length
changes in yeast38. Two of the four genes on CHRVIII—KOG1
and SCH9—found to be relevant to the suppression of telomerase
insufﬁciency and code for components of the TORC1 pathway
in S. cerevisiae. However, the combined haploinsufﬁciencies of
KOG1 and SCH9 are not enough to bypass telomerase
insufﬁciency (Fig. 5a). Additional inputs from the
insufﬁciencies in PRP8, UTP9 and other unidentiﬁed factors on
CHRVIII (since the combination of the four haploinsufﬁciencies
has not completely stabilised CHRVIII) are important for the
suppression of telomerase insufﬁciency. The connection between
the TOR pathway, telomere length regulation and lifespan
remains very intriguing. Human telomerase has been found in
a complex with mTOR39 and this association may be part of a
regulatory mechanism coordinating telomerase with cell growth
and proliferation.
The CHRVIII aneuploids are near diploids that originated
from haploid yeast with critically short telomeres. A switch to
tetraploidy in response to problem telomeres in precancerous
cells has recently been proposed as an early step in cancer
development40,41. Mammalian tetraploid cells are highly unstable
and become aneuploid, thereby promoting tumorigenesis42. One
can easily envision how the selection for aneuploids with
upregulation of telomerase could be the driving force for cancer
progression at the next stage. Another interesting conside-
ration is whether the well-established connection between
ribosomopathies (a group of pathologies linked to ribosome
biogenesis) and increased risk of cancer43 involves telomerase
upregulation. Therefore, studying aneuploidy as a means to
regulate telomerase levels may not only further our under-
standing of how simple organisms adapt to environmental
conditions but could also help to elucidate the mechanisms of
cancer and telomere syndromes in humans.
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Figure 7 | The effect of TLC1, EST1 and EST3 heterozygosity in 2n 1 (CHRVIII) yeast on cell viability during serial passaging at 38.5 C. Serial
passaging of isogenic aneuploid strains with the relevant genotypes shown on the left.
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Methods
Strains and plasmids. Strain genotypes and construction are described in
Supplementary Data Set 2. Plasmid pYT72 contains the last 500 bp of CDC13-
coding sequence fused in frame with the EST1-coding sequence followed by 500 bp
of CDC13 30 untranslated region, cloned as a HindIII–BamHI fragment in the
pRS406 integration vector. When linearized with EcoNI, the plasmid integrates
into the endogenous CDC13 locus thereby fusing the endogenous CDC13 to EST1.
pYT100 contains the C-terminal part of CDC13 fused to EST2, in the integration
vector pRS406. The plasmid was made by sub-cloning EagI–SalI fragment from
pVL1107 (ref. 24) into pRS406. When pYT100 is linearized with NruI, the plasmid
integrates at the endogenous CDC13 locus, thereby fusing the endogenous CDC13
to EST2. The 5- ﬂuoroorotic acid was used to select for cells after spontaneous loss
of the fusion construct (after telomere elongation).
To generate a 2n 1 (CHRVIII) aneuploid at 30 C, URA3 was integrated near
CHRVIII centromere (between QCR10 and LEU5) in a haploid strain with both
arms of CHRVIII marked with genetic markers (NAT and HYG). This haploid was
then crossed to another haploid with an unmarked CHRVIII to generate a diploid.
The diploid strain was then transformed with a recombinant PCR product, which
after recombining into the CHRVIII induces deletion of both URA3 and the
adjacent centromere, thereby leading to CHRVIII loss. Transformants were
selected on 5- ﬂuoroorotic acid, screened for the loss of the NAT and HYG markers
and then the CHRVIII loss was conﬁrmed by quantitative pulsed-ﬁeld gel
electrophoresis.
Yeast passaging and chromosome stability assays. Multiple independent
clones were streaked on YPD agar supplemented with additional 0.01% L-trypto-
phan, 0.01% adenine and 0.003% uracil and incubated at the corresponding
temperature for either 2–2.5 days (if grown at 26–37 C) or 3 days (if grown at 23
or 38.5 C) before being passaged onto plates with fresh media. To assay CHRVIII
stability in diploid cells, both copies of the chromosome were double marked. One
copy of the chromosome contained an HPH cassette between SPB1 and RPL8A on
the right arm and ARG4 on the left arm. The other copy of CHRVIII had a NAT
cassette and arg4::TRP1 at the respective loci. When effects of different deletions on
CHRVIII were analysed, such marking was not necessary if a deletion included at
least one essential gene. In this case, only the copy with the deletion could be
lost and such events were detected by the loss of the marker used to make the
deletion. After each passage, cells were tested for the presence of the genetic
markers on CHRVIII to calculate CHRVIII stability. Chromosome III stability in
matD::KAN /MATa cells was monitored by the presence of kanamycin resistance
and Mat-a.
FACS analysis. Cells exponentially growing in YPD broth were collected and re-
suspended in 70% ethanol. To ﬁx cells, samples were incubated for at least 2 h at
room temperature on a rotator, then washed three times with 50mM sodium
citrate and treated with 0.5mgml 1 RNase A at 37 C overnight. Cells were
washed from RNase A and stained with 1 mM SYBR Green I (Invitrogen) for 1 h at
room temperature, sonicated for 4 s and processed immediately using a Becton
Dickenson FACS Analyser. The FACS proﬁles of the experimental samples were
compared with the control samples of haploid and diploid strains.
Telomere analysis by Southern blotting. Telomere length and structure in
S.cerevisiae were analysed by telomere-speciﬁc Southern blotting. Brieﬂy, puriﬁed
yeast genomic DNA was digested either with KpnI (to analyse Y0 telomere length)
or with XhoI (to analyse all telomeres) and resolved on 0.85% agarose gel and
blotted onto a charged nylon membrane. Blots were hybridized to either KL1 probe
speciﬁc to the subtelomeric Y0 repeat44, or to (cccaca)4 oligonucleotide recognizing
telomeric sequences. For S. pombe telomere analysis, total genomic DNA was
digested with EcoRI and resolved on 1% agarose gel. A TAS1-speciﬁc probe45 was
used for hybridization. To analyse telomeres in C. vulgaris, BamHI was used to
digest genomic DNA, which then was resolved on 1.2% agarose gel. P-32
end-labelled oligonucleotide ccctaaaccctaaaccctaaaccc was used for Southern blot
hybridization.
Protein analysis by western blotting. For protein analysis, 5–10 optical densities
(ODs; OD600) of cells actively dividing either on plates (for Rad53-HA) or in liquid
culture (13myc-tagged Est1, Est2 or Est3) were used to prepare total protein
extracts by trichloroacetic acid precipitation46. Protein concentration in each
sample was measured using Bradford reagent (Bio-Rad) and equal amount of
protein was loaded in each lane on SDS–polyacrylamide gel electrophoresis. The
resolved proteins were transferred onto a polyvinylidene diﬂuoride membrane and
incubated with a corresponding primary antibody: rat monoclonal anti-HA at
1: 1,000 dilution (clone 3F10, Covance) or mouse monoclonal anti-myc at 1:1,000
dilution (9E10, Covance). Horseradish peroxidase -conjugated goat anti-rat
antibody at 1:10,000 dilution and ECL Plus detection kit (GE Healthcare) were then
used to visualize Rad53-HA. For the quantitative analysis of the myc-tagged Est1,
Est2 and Est3, secondary antibodies (goat anti-mouse IgG at 1:25,000) covalently
linked to infrared ﬂuorophore Alexa Fluor 680 (Invitrogen) were used. The blots
were then scanned using an Odyssey infrared imager and analysed with Image
Studio 2.0 software (LI-Cor Biosciences). The relative amounts of the telomerase
components were expressed as a myc signal normalized against total protein. Three
biological repeats using at least two independently constructed strains were used
for each measurement to calculate averages and s.d.s. Uncropped blots of all gels
appear as Supplementary Fig. 9.
RNA isolation and analysis. For total RNA isolation, yeast cultures were grown to
mid-exponential phase at 30 or 38.5 C and 15 ODs of each culture were collected
by centrifugation. Total RNA from each sample was isolated using the hot phenol
method47.
To quantify the relative amount of TLC1 RNA in cells with different genotypes,
5 mg of total RNA was glyoxyl denatured and resolved on 1.2% agarose gel48. The
gel was stained with ethidium bromide and imaged using Bio-Rad gel
documentation system. The relative amount of the 18S RNA in each lane was
quantiﬁed using Image Lab software (Bio-Rad). RNA was blotted onto a positively
charged nylon membrane and hybridized with a 32P-labelled probe (Prime-It II kit
for random prime labelling, Agilent) corresponding to the BglII–BclI fragment of
the TLC1 gene. The blots were exposed to phosphorstorage screens and scanned
using Typhoon scanner. The TLC1 signal in each lane was quantiﬁed using
ImageQuant software (GE Healthcare). For comparative analysis, TLC1 signal was
normalized against 18S RNA signal. Three biological repeats were used for each
measurement to calculate averages and s.d.s.
For quantitative analysis of rRNA, 15 mg of total RNA of each sample was mixed
with formamide loading buffer, heated for 5min at 75 C and loaded on a
denaturing gel: 8% acrylamide (19:1 acrylamide to bis-acrylamide ratio) 7.5M urea
gel in TBE buffer. The gel was run until bromophenol blue was released into the
lower chamber. The RNA was stained with ethidium bromide imaged using
Bio-Rad gel documentation system. The relative amount of the 5.8S, 5S and tRNA
in each lane was quantiﬁed using Image Lab software (Bio-Rad). Three biological
repeats were used for each measurement to calculate averages and s.d.s.
To analyse the pre-rRNA processing, 5 mg of total RNA was glyoxyl
denatured and resolved on 1.2% agarose gel48. The gel was stained with
ethidium bromide and imaged using Bio-Rad gel documentation system.
RNA was transferred onto a positively charged nylon membrane and hybridized
with 32P-labelled oligonucleotides 50-TGTTACCTCTGGGCCC-30 and
50-CGGTTTTAATTGTCCTA-30 to visualize 35S–27S rRNA and 20S rRNA,
respectively.
Array comparative genome hybridization. Total genomic DNA was puriﬁed
from telomerase insufﬁciency survivors and their derivatives as well as from a
diploid control strain NK2442 which was used as a reference. DNA samples were
submitted to Nimblegen (Roche) for labelling and hybridization to custom
designed 135K arrays tiling 16 chromosomes (non-repetitive sequences),
mitochondrion and Y0 repeats of S. cerevisiae.
Analysis of relative protein abundance by MS. Three independently generated
2n 1 aneuploids (genetically engineered at 30 C as described above) along with
their parental diploid strain were used in the experiment. Cells were grown to
mid-logarithmic stage at 38.5 C in rich media, collected by centrifugation and
frozen at  80 C.
The trichloroacetic acid–acetone-precipitated pellets of total yeast protein
samples46 were reconstituted in 250 ml of 8M urea, and protein concentration was
measured using Bradford reagent (Bio-Rad). One milligram of protein extract was
mixed with 25ml of 1M ammonium bicarbonate and 25 ml of 200mM
dithiothreitol to enable denaturation and reduction of the proteins during
incubation at room temperature for 30min. For cysteine alkylation, 25 ml of
500mM iodoacetamide was added to each sample and incubated for 1 h at room
temperature. Samples were diluted with water to reduce urea concentration to 2M,
20 mg of trypsin was added to each sample and the protein digestions were
performed overnight at room temperature. Peptide extracts were then cleaned on
Bond Elut 25mg SPE reverse phase according to supplier’s recommendations
(Agilent, UK), then dried in a speedvac concentrator (ThermoFisher, UK) and
stored at  20 C. The dried peptide samples were re-suspended in 0.05%
triﬂuoroacetic acid (TFA) to a ﬁnal concentration of 1 mg ml 1. These samples were
ﬁltered using Millex ﬁlter (Millipore, UK) before being subjected to
HPLC–MS analysis (5 mg of each sample was injected).
Nano-HPLC-MS/MS analysis was performed using an online system consisting
of a nano-pump (Dionex Ultimate 3000, Thermo-Fisher, UK) coupled to a
QExactive instrument (Thermo-Fisher, UK) with a pre-column of 300 mm 5mm
(Acclaim Pepmap, 5 mm particle size) connected to a column of 75 mm 50 cm
(Acclaim Pepmap, 3 mm particle size). Samples were analysed on a 2-h gradient in
data-dependent analysis (1 survey scan at 70 k resolution followed by the top
10 MS/MS at 17.5 k resolution).
Progenesis (version 4.1 Nonlinear Dynamics, UK) was used for LC–MS
label-free quantitation. Only MS/MS peaks with a charge of 2þ , 3þ or 4þ were
taken into account for the total number of ‘Feature’ (signal at one particular
retention time and m/z) and only the ﬁve most intense spectra per ‘Feature’ were
considered in the analysis. Normalization was ﬁrst performed based on the sum of
the ion intensities of these sets of multi-charged ions (2þ , 3þ and 4þ ). The
associated unique peptide ion intensities for a speciﬁc protein were then summed
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to generate an abundance value. The abundance was then transformed using an
ArcSinH function (a log transform is not ideal considering the signiﬁcant amount
of near-zero measurements generated by the current method of detection). On the
basis of the abundance values calculated in three biological repeats for both diploid
and aneuploids stains, within group means were calculated and from there the fold
changes (in comparison with wild-type) were evaluated. One-way analysis of
variance was used to calculate the P values based on the transformed values.
Differentially expressed proteins were only considered signiﬁcant in current study
if the following conditions were fulﬁlled: (i) P values (pair wise)o0.05; (ii) number
of peptides detected and used in quantiﬁcation per protein was equal to or more
than 2; and (iii) absolute fold change was at least 1.5.
Data from MS/MS spectra were searched using MASCOT Versions 2.4 (Matrix
Science Ltd, UK) against the S. cerevisiae subset of the NCBI protein database
including contaminant and reverse sequence for a total of 12,288 sequences with
maximum missed-cut value set to 2. Following features were used in all searches:
(i) variable methionine oxidation; (ii) ﬁxed cysteine carbamidomethylation;
(iii) precursor mass tolerance of 10 p.p.m.; (iv) MS/MS tolerance of 0.05 AMU;
(v) signiﬁcance threshold (p) below 0.05 (MudPIT scoring); and (vi) ﬁnal peptide
score of 20, which correspond to o1% FDR. Gene name and secondary Identiﬁer
(with gene locus information) was performed using Saccharomyces Genome
Database (October 2014, www.yeastgenome.org). GO enrichment strategy was
performed on the two signiﬁcantly differentially expressed group (up- and
downregulated) using a two unranked lists of gene approach (each signiﬁcantly
differentially expressed groups against the pool of identiﬁed protein, which are not
differentially expressed identiﬁed in the study) using GOrilla tools49.
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